Very friendly and knowledgeable
Use a written protocol and, where possible, calibrated dispensing instead of freehand syringe draws
Despite precise targeting, some patients may still experience facial numbness
Its best to ask your insurance about it
Studies in inflammatory bowel disease models show KPV reducing intestinal inflammation markers without the systemic immunosuppressive effects associated with conventional treatments
The decision to continue, adjust, or discontinue therapy should be based on objective body composition measurements (DEXA scans, circumference measurements), achievement of fat loss goals, tolerance and side effect profile, and physician assessment of metabolic markers